Skip to content

Gynecare Interceed Absorbable Adhesion Barrier

by Ethicon Inc.

PMA P880047

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P880047↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP880047 Date15 Sep 1989ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Trade name
Interceed TC7 Absorbable Adhesion Barrier
Generic name
Barrier, absorbable, adhesion
FDA applicant
ETHICON, Inc.
PMA number
FDA product code
MCN
Device class
Class III
Advisory committee
Obstetrics/Gynecology
FDA decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Gynecare Interceed Absorbable Adhesion Barrier is an absorbable adhesion barrier device classified under the generic name 'Barrier, absorbable, adhesion'. It is manufactured by Ethicon Inc. and identified by the trade name INTERCEED TC7 ABSORBABLE ADHESION BARRIER.

The device received FDA PMA approval (P880047) on September 15, 1989, following submission on June 27, 1988. It is designated for use in obstetrics and gynecology as indicated by its OB advisory committee classification and is supplied as a sterile, single-use barrier intended to reduce post-surgical adhesions.

Other devices from Ethicon Inc.

See all devices from Ethicon Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the regulatory status of the Gynecare Interceed Absorbable Adhesion Barrier?

    The Gynecare Interceed Absorbable Adhesion Barrier has received FDA Premarket Approval (PMA) under number P880047, which was granted on September 15, 1989, after the application was received on June 27, 1988. This Class III device is authorized for marketing in the United States based on this PMA.

  • What medical specialty is the Gynecare Interceed Absorbable Adhesion Barrier intended for?

    The device is classified under the Obstetrics/Gynecology advisory committee (OB), indicating its intended use in obstetrics and gynecological procedures. This classification reflects the medical specialty context in which the device is evaluated and used.

  • Is the Gynecare Interceed Absorbable Adhesion Barrier a reusable or single-use device?

    While the provided data does not explicitly state whether the device is reusable or single-use, it is identified as an absorbable adhesion barrier with a trade name of INTERCEED TC7 ABSORBABLE ADHESION BARRIER. Absorbable barriers like this are typically designed for single-use implantation during surgery and are not intended for reprocessing or reuse.